EMA

Leqembi official photo

Pharma

European regulators spurn Eisai and Biogen's Alzheimer's med

Despite winning approvals in a range of countries, Eisai and Biogen’s Alzheimer’s disease med Leqembi has come up short with European regulators.

Fraiser Kansteiner Jul 26, 2024 9:42am

Mirati

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe

Jul 21, 2023 12:20pm

Sanofi

Sanofi's Lemtrada goes under EU review for fatal side effects

Apr 15, 2019 11:35am

German regulators yank Dr. Reddy’s certificate from India plant

Aug 15, 2017 8:34am

Supreme Court

Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale;

Mar 1, 2016 11:30am